Liu Bo, Chen Zhihao, Dong Xiaoqi, Qin Guangming
Department of Laboratory, School of Medicine, Second Affiliated Hospital, Zhejiang University, Hangzhou, China.
Department of Infectious Diseases, School of Medicine, Second Affiliated Hospital, Zhejiang University, Hangzhou, China.
BMJ Open. 2018 Mar 19;8(3):e019829. doi: 10.1136/bmjopen-2017-019829.
Comorbid hypertension and hyperhomocysteinemia is an important risk factor for carotid atherosclerotic plaque formation. We put forward the hypothesis that the subjects with comorbid prehypertension and hyperhomocysteinemia also had an increased risk of subclinical atherosclerosis, using carotid intima-media thickness (CIMT) as the marker of the atherosclerotic process.
A total of 4102 asymptomatic Chinese subjects aged 18-60 years were divided into four groups according to blood pressure (BP) and homocysteine (HCY) level: the control group without prehypertension or hyperhomocysteinemia, isolated prehypertension group, simple hyperhomocysteinemia group and prehypertension with hyperhomocysteinemia group. Serum lipids, fasting blood glucose (FBG), HCY and CIMT were measured.
There was significant difference in the positive rates of increased CIMT among four groups. Compared with the controls, the subjects in the other three groups had a higher risk of increased CIMT (isolated prehypertension group, OR 2.049, 95% CI 1.525 to 2.754; simple hyperhomocysteinemia group, OR 2.145, 95% CI 1.472 to 3.125; prehypertension and hyperhomocysteinemia group, OR 3.199, 95% CI 2.362 to 4.332). However, by multiple logistic regression analysis, only comorbid prehypertension and hyperhomocysteinemia was independently associated with increased CIMT (OR 1.485, 95% CI 1.047 to 2.108, P<0.05).
Comorbid prehypertension and hyperhomocysteinemia was an independent risk factor of subclinical atherosclerosis in asymptomatic Chinese, but isolated prehypertension or hyperhomocysteinemia was not. Therefore, combined intervention for prehypertension and hyperhomocysteinemia may contribute to decrease the incident of cardiovascular disease.
高血压合并高同型半胱氨酸血症是颈动脉粥样硬化斑块形成的重要危险因素。我们提出假设,即使用颈动脉内膜中层厚度(CIMT)作为动脉粥样硬化进程的标志物,合并临界高血压和高同型半胱氨酸血症的受试者发生亚临床动脉粥样硬化的风险也会增加。
总共4102名年龄在18至60岁之间的无症状中国受试者,根据血压(BP)和同型半胱氨酸(HCY)水平分为四组:无临界高血压或高同型半胱氨酸血症的对照组、单纯临界高血压组、单纯高同型半胱氨酸血症组和临界高血压合并高同型半胱氨酸血症组。测量血脂、空腹血糖(FBG)、HCY和CIMT。
四组中CIMT增加的阳性率存在显著差异。与对照组相比,其他三组受试者CIMT增加的风险更高(单纯临界高血压组,OR 2.049,95%CI 1.525至2.754;单纯高同型半胱氨酸血症组,OR 2.145,95%CI 1.472至3.125;临界高血压合并高同型半胱氨酸血症组,OR 3.199,95%CI 2.362至4.332)。然而,通过多因素逻辑回归分析,只有临界高血压合并高同型半胱氨酸血症与CIMT增加独立相关(OR 1.485,95%CI 1.047至2.108,P<0.05)。
临界高血压合并高同型半胱氨酸血症是无症状中国人亚临床动脉粥样硬化的独立危险因素,但单纯临界高血压或高同型半胱氨酸血症不是。因此,对临界高血压和高同型半胱氨酸血症进行联合干预可能有助于降低心血管疾病的发生率。